World's Best Scientists 2026 revealed!
Olivia M. Dean

Olivia M. Dean

D-Index & Metrics

Psychology

D-Index
56
Citations
17021
World Ranking
4131
National Ranking
221

Olivia M. Dean publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Olivia M. Dean sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 344 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 34 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–705 publications: 5 scientists 706+ publications: 100 scientists
31 publications 706+

This scientist: 217 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 706 publications or more.

Olivia M. Dean D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Olivia M. Dean sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 559 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 87 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 79 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 56 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Olivia M. Dean is affiliated with Deakin University in Australia and has predominantly contributed to the fields of Medicine and Neuroscience. Their research output spans various subfields including Psychiatry and Mental Health, Clinical Psychology, Biological Psychiatry, Molecular Biology, and Genetics.

The scientist's research largely focuses on topics related to Bipolar Disorder and Treatment, Tryptophan and Brain Disorders, Schizophrenia Research and Treatment, Child and Adolescent Psychosocial and Emotional Development, Treatment of Major Depression, Mental Health Research Topics, and Stress Responses and Cortisol.

Frequent venues for Olivia M. Dean's publications include the Journal of Affective Disorders, Australian & New Zealand Journal of Psychiatry, Bipolar Disorders, International Journal of Molecular Sciences, and bioRxiv (Cold Spring Harbor Laboratory).

Notable recent papers authored or coauthored by Olivia M. Dean include:

  • Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management, 2023, World Psychiatry
  • Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce, 2022, The World Journal of Biological Psychiatry
  • Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trials, 2020, Neuroscience & Biobehavioral Reviews
  • Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin, 2020, BMC Medicine
  • Prebiotic and probiotic supplementation and the tryptophan-kynurenine pathway: A systematic review and meta analysis, 2021, Neuroscience & Biobehavioral Reviews

Olivia M. Dean has collaborated extensively with a group of frequent coauthors, including Michael Berk, Alyna Turner, Adam J. Walker, Ken Walder, and Sue Cotton.

Best Publications

  • Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

    Michael Berk;Flavio P Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;Olivia Dean;Olivia Dean

  • Oxidative stress in psychiatric disorders : evidence base and therapeutic implications

    Felicity Ng;Michael Berk;Michael Berk;Olivia Dean;Ashley I. Bush

  • A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial)

    Felice N Jacka;Adrienne O'Neil;Adrienne O'Neil;Rachelle Opie;Rachelle Opie;Catherine Itsiopoulos

  • The chemistry and biological activities of N-acetylcysteine

    Yuval Samuni;Sara Goldstein;Olivia M. Dean;Olivia M. Dean;Olivia M. Dean;Michael Berk

  • N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

    Michael Berk;David Leon Copolov;David Leon Copolov;Olivia Dean;Olivia Dean;Kristy Lu

  • N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

    Olivia Dean;Frank Giorlando;Michael Berk

  • N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

    Michael Berk;Michael Berk;David Leon Copolov;David Leon Copolov;Olivia Dean;Kristy Lu

  • The promise of N-acetylcysteine in neuropsychiatry.

    Michael Berk;Gin S. Malhi;Gin S. Malhi;Laura J. Gray;Olivia M. Dean;Olivia M. Dean;Olivia M. Dean

  • N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

    Seetal Dodd;Olivia Dean;David Leon Copolov;Gin S Malhi

  • Oxidative & nitrosative stress in depression: why so much stress?

    Steven Moylan;Steven Moylan;Michael Berk;Olivia Dean;Yuval Samuni

  • Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

    Deepmala;Deepmala;John Slattery;Nihit Kumar;Leanna Delhey

  • A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

    Justin Davis;Harris Eyre;Felice N Jacka;Seetal Dodd

  • Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

    Michael Berk;Olivia Dean;Olivia Dean;Olivia Dean;Hemmo Drexhage;John James McNeil

  • C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.

    Fernandes Bs;Steiner J;Bernstein Hg;Dodd S;Dodd S

  • Post-Operative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies.

    David R Skvarc;Michael Berk;Michael Berk;Linda K Byrne;Olivia M Dean

  • Glutathione: a novel treatment target in psychiatry.

    Michael Berk;Michael Berk;Felicity Ng;Olivia Dean;Seetal Dodd

  • Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

    Unknown

  • The glutathione system: a new drug target in neuroimmune disorders.

    Gerwyn Morris;George Anderson;Olivia Dean;Michael Berk;Michael Berk

  • The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial ☆

    Michael Berk;Olivia Dean;Olivia Dean;Olivia Dean;Sue M. Cotton;Clarissa S. Gama

  • The efficacy of adjunctive N-acetylcysteine in major depressive disorder : a double-blind, randomized, placebo-controlled trial

    Michael Berk;Olivia M Dean;Sue M Cotton;Susan Jeavons

  • Minocycline: therapeutic potential in psychiatry.

    Olivia M Dean;João Data-Franco;Francesco Giorlando;Michael Berk

Frequent Co-Authors

Chee H. Ng
Chee H. Ng University of Melbourne
David J. Castle
David J. Castle University of Tasmania
Andrew M. Chanen
Andrew M. Chanen University of Melbourne
Christopher G. Davey
Christopher G. Davey University of Melbourne
Dan I. Lubman
Dan I. Lubman Monash University
Susan L. Rossell
Susan L. Rossell Swinburne University of Technology
Rebecca McKetin
Rebecca McKetin University of New South Wales
Amanda L. Baker
Amanda L. Baker University of Newcastle Australia
Victoria Manning
Victoria Manning Monash University
Simon M Rice
Simon M Rice University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in studying Psychology in the USA, a variety of online degree programs are available to help you start or advance your career. Psychology degrees not only provide a solid foundation in understanding human behavior but also open doors to specialized roles, such as substance abuse counseling and mental health support.

To become a substance abuse counselor, it is crucial to understand the certification requirements, which differ widely depending on the state or city. For example, if you're curious about how to become a substance abuse counselor in Minneapolis, you'll discover specific educational and supervised experience prerequisites. Similarly, the Nashville substance abuse counselor certification requirements and those for New Orleans substance abuse counselor certification requirements highlight the unique accreditation and licensing standards in each area.

For those exploring opportunities in larger metropolitan areas, becoming a substance abuse counselor in New York City requires navigating comprehensive certification pathways. Choosing an online psychology program with a focus on counseling can enhance your knowledge and flexibility, helping you meet local requirements and prepare for a rewarding career.

Best Scientists Citing Olivia M. Dean

Trending Scientists

Recently Published Articles